Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2003
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130355C Thienyl-, furyl-, pyrrolyl-and biphenylsulfonamides and derivatives thereof modulate activity of endothelin
12/10/2003CN1130349C H3 receptor liqands of phenyl-alkyl-imidazoles type
12/10/2003CN1130347C 2,3-methylene amino acid compounds, their preparing method and pharmaceutical composition containing them
12/09/2003US6660891 Methods for the production of D-chiro-inositol and the use of D-chiro inositol obtained therefrom
12/09/2003US6660879 Use of the compound in clinical conditions associated with insulin resistance.
12/09/2003US6660859 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases
12/09/2003US6660830 Peptides with antiproliferative properties
12/09/2003US6660767 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660759 4.5-diaryloxazole compounds with prostaglandin I2 (PGI2) agonistic activity
12/09/2003US6660752 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
12/09/2003US6660751 Sulfonamide derivatives as 5-HT7 receptor antagonists
12/09/2003US6660746 Cardiovascular disorders
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660737 Medicinal uses of hydrazones
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660728 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
12/09/2003US6660724 Compounds and pharmaceutical compositions containing them
12/09/2003US6660474 Identifying individuals predisposed to essential hypertension and related conditions such as salt sensitivity by detecting the presence of polymorphic or mutant forms of the GRK4 gene, or its expression product.
12/09/2003US6659282 Antiinflammatory lipoxing derivatives
12/09/2003CA2140247C Novel vitamin d analogues
12/09/2003CA2078758C 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
12/04/2003WO2003100438A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003WO2003100435A2 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
12/04/2003WO2003100087A2 Regulation of novel human asparagine-hydroxylases
12/04/2003WO2003100008A2 Neutralizing human anti-igfr antibody
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099836A1 C-aryl glucoside sglt2 inhibitors and method
12/04/2003WO2003099827A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099821A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
12/04/2003WO2003099818A1 Substituted quinazolinone compounds
12/04/2003WO2003099813A1 Novel physiolgically active substances
12/04/2003WO2003099808A1 Substituted heterocyclic compounds and methods of use
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003WO2003099795A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors
12/04/2003WO2003099790A1 Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
12/04/2003WO2003099788A1 Piperidine derivatives
12/04/2003WO2003099781A2 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
12/04/2003WO2003099775A1 Sulfone liver x-receptor modulators
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003WO2003099767A1 Amide derivatives as inhibitors of the enzymatic activity of renin
12/04/2003WO2003099766A1 (2s)-2-ethylphenylpropionic acid derivative
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099764A1 ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS
12/04/2003WO2003099762A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003WO2003099759A1 Preparation and application of transhintotalphenolic acid
12/04/2003WO2003099337A2 Inclusion complexes of rosiglitazone
12/04/2003WO2003099336A1 Formulation for parenteral administration of sodium channel blockers
12/04/2003WO2003099335A1 Potassium alginate as pharmaceutical excipient and compositions thereof
12/04/2003WO2003099331A1 Insulin resistance improving agents
12/04/2003WO2003099326A1 Novel uses of parapoxvirus preparations
12/04/2003WO2003099323A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
12/04/2003WO2003099321A1 Methods for preventing, treating or delaying cardiac toxicity using neuregulin
12/04/2003WO2003099320A1 Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
12/04/2003WO2003099319A1 Preventive/remedy for arteriosclerosis
12/04/2003WO2003099315A1 A pharmaceutical composition comprising a retro-iverso isomer peptide
12/04/2003WO2003099314A1 Novel exendin agonist formulations and methods of administration thereof
12/04/2003WO2003099300A1 Neuregulin based methods and compositions for treating cardiovascular diseases
12/04/2003WO2003099288A1 Medicinal composition
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099280A1 Novel formulation for the parenteral application of crobenetine
12/04/2003WO2003099279A1 Combination of a dpp iv inhibitor and a cardiovascular compound
12/04/2003WO2003099226A2 Antibody peg positional isomers, compositions comprising same, and use thereof
12/04/2003WO2003099221A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003WO2003099215A2 Antisense modulation of glucocorticoid receptor expression
12/04/2003WO2003099201A2 Compositions and methods of use for a fibroblast growth factor
12/04/2003WO2003099195A2 Immunomodulatory compounds and methods of use thereof
12/04/2003WO2003099194A2 Pharmaceutical combination of pde5 inhibitors with ace inhibitors
12/04/2003WO2003099192A2 Bis-aromatic alkanols
12/04/2003WO2003099011A1 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
12/04/2003WO2003090818A3 Drug-delivery endovascular stent and method for treating restenosis
12/04/2003WO2003086309A3 NF-κB INHIBITORS
12/04/2003WO2003082196A3 Combination therapy using trefoil peptides
12/04/2003WO2003080841A8 Calcineurin activators
12/04/2003WO2003075928A3 Stable pharmaceutical compositions
12/04/2003WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/04/2003WO2003074485A3 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors
12/04/2003WO2003072062A3 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/04/2003WO2003064596A3 Desaturase genes, enzymes encoded thereby, and uses thereof
12/04/2003WO2003063846A3 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions
12/04/2003WO2003059878A3 Thieno (3, 2-b) pyridones as antiviral compounds
12/04/2003WO2003059875A3 DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION
12/04/2003WO2003059807A3 Crystalline solids of carvedilol and processes for their preparation
12/04/2003WO2003057380A3 Compositions including ammonia oxidizing bacteria and methods of using same
12/04/2003WO2003057170A3 Oral insulin therapy
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003WO2003050281A3 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity
12/04/2003WO2003049692A3 The use of acyl salicylates as heat shock inducers
12/04/2003WO2003046141A3 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
12/04/2003WO2003039523A3 OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
12/04/2003WO2003030867A3 Method for preparing an interactive compound of an anilide derivative with a porous support by supercritical fluid
12/04/2003WO2003028715A3 Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
12/04/2003WO2003027085A3 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
12/04/2003WO2003026590A3 Biological control of nanoparticles
1 ... 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 ... 1595